MENU
+Compare
IMRX
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$1.47
Change
+$0.06 (+4.26%)
Capitalization
49.66M

IMRX Immuneering Corp Forecast, Technical & Fundamental Analysis

Immuneering Corp is a biopharmaceutical company... Show more

IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for IMRX with price predictions
Apr 23, 2025

Momentum Indicator for IMRX turns positive, indicating new upward trend

IMRX saw its Momentum Indicator move above the 0 level on April 22, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 72 similar instances where the indicator turned positive. In of the 72 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMRX's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IMRX just turned positive on April 22, 2025. Looking at past instances where IMRX's MACD turned positive, the stock continued to rise in of 31 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IMRX advanced for three days, in of 182 cases, the price rose further within the following month. The odds of a continued upward trend are .

IMRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

IMRX moved below its 50-day moving average on March 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for IMRX moved below the 200-day moving average on March 31, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IMRX entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IMRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.200) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IMRX is expected to report earnings to fall 15.52% to -49 cents per share on May 13

Immuneering Corp IMRX Stock Earnings Reports
Q1'25
Est.
$-0.49
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.01
The last earnings report on March 20 showed earnings per share of -57 cents, missing the estimate of -44 cents. With 50.47K shares outstanding, the current market capitalization sits at 49.66M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPFI8.860.42
+4.98%
OppFi
ZI8.230.29
+3.65%
ZoomInfo Technologies
HYLN1.570.05
+3.29%
Hyliion Holdings Corp
DCBO30.200.73
+2.48%
Docebo
ICE160.990.31
+0.19%
Intercontinental Exchange

IMRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with SPRB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
+3.62%
SPRB - IMRX
52%
Loosely correlated
+2.39%
NUVL - IMRX
40%
Loosely correlated
+1.85%
VRDN - IMRX
30%
Poorly correlated
-1.82%
INSM - IMRX
30%
Poorly correlated
-0.70%
ORMP - IMRX
29%
Poorly correlated
+0.66%
More